Adoption is real. Operating maturity is scarce. This evidence-backed briefing separates the signal from the theatre and gives leaders a practical path forward.
Evidence current through July 30, 2026
12 concise, source-linked pages
Built for biotech executives and operating leaders
COMPLIMENTARY EXECUTIVE REPORT
Get the 12-page briefing.
No phone number. No mailing-list trap. Just the report.
HaiPhai will use this information to deliver the report and follow up about your interest. We do not sell contact information. See our privacy notice.
INSIDE THE REPORT
A briefing designed to create a better leadership conversation.
01
Adoption versus maturity
A clear read on why AI use is spreading faster than repeatable, governed operating capability.
02
The regulatory direction
What FDA, EMA, NIST, and the EU are signaling about context, evidence, oversight, and lifecycle control.
03
An executive action system
A maturity model, ten-question scorecard, and practical 90-day agenda leaders can use immediately.
EVIDENCE, NOT THEATRE
Sources are visible. Interpretation is labeled.
The report synthesizes current FDA and EMA materials, a UK government engineering-biology survey, NIST guidance, the EU AI Act, NIH strategy, peer-reviewed literature, and clearly attributed industry surveys.
It includes no invented client results, proprietary benchmarks, or unsupported ROI claims.